Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: Final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial-Reference-Cited by-同舟云学术

Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: Final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial

Published:2013-12 Issue:6 Volume:166 Page:1035-1042
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Brener Sorin J.,Kereiakes Dean J.,Simonton Charles A.,Rizvi Ali,Newman William,Mastali Kourosh,Wang John C.,Caputo Ronald,Smith Robert S.,Ying Shih-Wa,Cutlip Donald E.,Stone Gregg W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. 2-year patient-related versus stent-related outcomes: The SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial;Jensen;J Am Coll Cardiol,2012

2. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial;Silber;Lancet,2011

3. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease;Stone;N Engl J Med,2010

4. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial;Stone;J Am Coll Cardiol,2011

5. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease;Nikolsky;Am Heart J,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study;Heliyon;2023-08

2. Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases;Frontiers in Cell and Developmental Biology;2023-03-16

3. Durable Polymer Everolimus Eluting Stents;Interventional Cardiology;2022-05-06

4. In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches;Life;2022-03-08